Structure and mechanisms of transport of human Asc1/CD98hc amino acid transporter.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
06 Apr 2024
Historique:
received: 10 10 2023
accepted: 29 03 2024
medline: 7 4 2024
pubmed: 7 4 2024
entrez: 6 4 2024
Statut: epublish

Résumé

Recent cryoEM studies elucidated details of the structural basis for the substrate selectivity and translocation of heteromeric amino acid transporters. However, Asc1/CD98hc is the only neutral heteromeric amino acid transporter that can function through facilitated diffusion, and the only one that efficiently transports glycine and D-serine, and thus has a regulatory role in the central nervous system. Here we use cryoEM, ligand-binding simulations, mutagenesis, transport assays, and molecular dynamics to define human Asc1/CD98hc determinants for substrate specificity and gain insights into the mechanisms that govern substrate translocation by exchange and facilitated diffusion. The cryoEM structure of Asc1/CD98hc is determined at 3.4-3.8 Å resolution, revealing an inward-facing semi-occluded conformation. We find that Ser 246 and Tyr 333 are essential for Asc1/CD98hc substrate selectivity and for the exchange and facilitated diffusion modes of transport. Taken together, these results reveal the structural bases for ligand binding and transport features specific to human Asc1.

Identifiants

pubmed: 38582862
doi: 10.1038/s41467-024-47385-3
pii: 10.1038/s41467-024-47385-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2986

Subventions

Organisme : "la Caixa" Foundation (Caixa Foundation)
ID : LCF/PR/HR20/52400017

Informations de copyright

© 2024. The Author(s).

Références

Fukasawa, Y. et al. Identification and characterization of a Na(+)-independent neutral amino acid transporter that associates with the 4F2 heavy chain and exhibits substrate selectivity for small neutral D- and L-amino acids. J. Biol. Chem. 275, 9690–9698 (2000).
pubmed: 10734121 doi: 10.1074/jbc.275.13.9690
Nakauchi, J. et al. Cloning and characterization of a human brain Na(+)-independent transporter for small neutral amino acids that transports D-serine with high affinity. Neurosci. Lett. 287, 231–235 (2000).
pubmed: 10863037 doi: 10.1016/S0304-3940(00)01169-1
Sakimura, K., Nakao, K., Yoshikawa, M., Suzuki, M. & Kimura, H. A novel Na(+) -Independent alanine-serine-cysteine transporter 1 inhibitor inhibits both influx and efflux of D-Serine. J. Neurosci. Res. 94, 888–895 (2016).
pubmed: 27302861 doi: 10.1002/jnr.23772
Suzuki, M. et al. Serum D-serine accumulation after proximal renal tubular damage involves neutral amino acid transporter Asc-1. Sci. Rep. 9, 16705 (2019).
pubmed: 31723194 pmcid: 6853873 doi: 10.1038/s41598-019-53302-2
Jersin, R. A., Jonassen, L. R. & Dankel, S. N. The neutral amino acid transporter SLC7A10 in adipose tissue, obesity and insulin resistance. Front. Cell Dev. Biol. 10, 974338 (2022).
pubmed: 36172277 pmcid: 9512047 doi: 10.3389/fcell.2022.974338
Rullo-Tubau, J., Bartoccioni, P., Llorca, O., Errasti-Murugarren, E. & Palacin, M. HATs meet structural biology. Curr. Opin. Struct. Biol. 74, 102389 (2022).
pubmed: 35605357 doi: 10.1016/j.sbi.2022.102389
Pineda, M. et al. The amino acid transporter asc-1 is not involved in cystinuria. Kidney Int. 66, 1453–1464 (2004).
pubmed: 15458438 doi: 10.1111/j.1523-1755.2004.00908.x
Sason, H. et al. Asc-1 transporter regulation of synaptic activity via the tonic release of d-Serine in the forebrain. Cereb. Cortex 27, 1573–1587 (2017).
pubmed: 26796213
Gauthier-Coles, G. et al. Quantitative modelling of amino acid transport and homeostasis in mammalian cells. Nat. Commun. 12, 5282 (2021).
pubmed: 34489418 pmcid: 8421413 doi: 10.1038/s41467-021-25563-x
Coyle, J. T., Balu, D. & Wolosker, H. D-Serine, the shape-shifting NMDA receptor Co-agonist. Neurochem. Res. 45, 1344–1353 (2020).
pubmed: 32189130 pmcid: 7313399 doi: 10.1007/s11064-020-03014-1
Rosenberg, D. et al. Neuronal D-serine and glycine release via the Asc-1 transporter regulates NMDA receptor-dependent synaptic activity. J. Neurosci. 33, 3533–3544 (2013).
pubmed: 23426681 pmcid: 6619521 doi: 10.1523/JNEUROSCI.3836-12.2013
Brown, J. M. et al. In vitro characterization of a small molecule inhibitor of the alanine serine cysteine transporter -1 (SLC7A10). J. Neurochem. 129, 275–283 (2014).
pubmed: 24266811 doi: 10.1111/jnc.12618
Kutchukian, P. S. et al. Iterative focused screening with biological fingerprints identifies selective Asc-1 inhibitors distinct from traditional high throughput screening. ACS Chem. Biol. 12, 519–527 (2017).
pubmed: 28032990 doi: 10.1021/acschembio.6b00913
Lai, T. W., Zhang, S. & Wang, Y. T. Excitotoxicity and stroke: identifying novel targets for neuroprotection. Prog. Neurobiol. 115, 157–188 (2014).
pubmed: 24361499 doi: 10.1016/j.pneurobio.2013.11.006
Hansen, K. B. et al. Structure, function, and pharmacology of glutamate receptor ion channels. Pharm. Rev. 73, 298–487 (2021).
pubmed: 34753794 pmcid: 8626789 doi: 10.1124/pharmrev.120.000131
Arianti, R. et al. ASC-1 transporter-dependent amino acid uptake is required for the efficient thermogenic response of human adipocytes to adrenergic stimulation. FEBS Lett. 595, 2085–2098 (2021).
pubmed: 34197627 doi: 10.1002/1873-3468.14155
Jersin, R. A. et al. Role of the neutral amino acid transporter SLC7A10 in adipocyte lipid storage, obesity, and insulin resistance. Diabetes 70, 680–695 (2021).
pubmed: 33408126 doi: 10.2337/db20-0096
Suwandhi, L. et al. Asc-1 regulates white versus beige adipocyte fate in a subcutaneous stromal cell population. Nat. Commun. 12, 1588 (2021).
pubmed: 33707431 pmcid: 7952576 doi: 10.1038/s41467-021-21826-9
Yan, R., Zhao, X., Lei, J. & Zhou, Q. Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex. Nature 568, 127–130 (2019).
pubmed: 30867591 doi: 10.1038/s41586-019-1011-z
Lee, Y. et al. Cryo-EM structure of the human L-type amino acid transporter 1 in complex with glycoprotein CD98hc. Nat. Struct. Mol. Biol. 26, 510–517 (2019).
pubmed: 31160781 doi: 10.1038/s41594-019-0237-7
Rodriguez, C. F. et al. Structural basis for substrate specificity of heteromeric transporters of neutral amino acids. Proc. Natl. Acad. Sci. USA 118, e2113573118 (2021).
pubmed: 34848541 pmcid: 8670485 doi: 10.1073/pnas.2113573118
Parker, J. L. et al. Molecular basis for redox control by the human cystine/glutamate antiporter system xc(). Nat. Commun. 12, 7147 (2021).
pubmed: 34880232 pmcid: 8654953 doi: 10.1038/s41467-021-27414-1
Yan, R. et al. Cryo-EM structure of the human heteromeric amino acid transporter b(0,+)AT-rBAT. Sci. Adv. 6, eaay6379 (2020).
pubmed: 32494597 pmcid: 7159911 doi: 10.1126/sciadv.aay6379
Wu, D. et al. Structural basis for amino acid exchange by a human heteromeric amino acid transporter. Proc. Natl. Acad. Sci. USA 117, 21281–21287 (2020).
pubmed: 32817565 pmcid: 7474693 doi: 10.1073/pnas.2008111117
Yan, R. et al. Mechanism of substrate transport and inhibition of the human LAT1-4F2hc amino acid transporter. Cell Discov. 7, 16 (2021).
pubmed: 33758168 pmcid: 7988154 doi: 10.1038/s41421-021-00247-4
Lee, Y. et al. Ca(2+)-mediated higher-order assembly of heterodimers in amino acid transport system b(0,+) biogenesis and cystinuria. Nat. Commun. 13, 2708 (2022).
pubmed: 35577790 pmcid: 9110406 doi: 10.1038/s41467-022-30293-9
Jeckelmann, J. M., Lemmin, T., Schlapschy, M., Skerra, A. & Fotiadis, D. Structure of the human heterodimeric transporter 4F2hc-LAT2 in complex with Anticalin, an alternative binding protein for applications in single-particle cryo-EM. Sci. Rep. 12, 18269 (2022).
pubmed: 36310334 pmcid: 9618567 doi: 10.1038/s41598-022-23270-1
Yan, R., Zhou, J., Li, Y., Lei, J. & Zhou, Q. Structural insight into the substrate recognition and transport mechanism of the human LAT2-4F2hc complex. Cell Discov. 6, 82 (2020).
pubmed: 33298890 pmcid: 7653941 doi: 10.1038/s41421-020-00207-4
Mikou, A. et al. Asc-1 transporter (SLC7A10): homology models and molecular dynamics insights into the first steps of the transport mechanism. Sci. Rep. 10, 3731 (2020).
pubmed: 32111919 pmcid: 7048771 doi: 10.1038/s41598-020-60617-y
Punjani, A., Zhang, H. & Fleet, D. J. Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nat. Methods 17, 1214–1221 (2020).
pubmed: 33257830 doi: 10.1038/s41592-020-00990-8
Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583–589 (2021).
pubmed: 34265844 pmcid: 8371605 doi: 10.1038/s41586-021-03819-2
Varadi, M. et al. AlphaFold protein structure database: massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res. 50, D439–D444 (2022).
pubmed: 34791371 doi: 10.1093/nar/gkab1061
Errasti-Murugarren, E. et al. L amino acid transporter structure and molecular bases for the asymmetry of substrate interaction. Nat. Commun. 10, 1807 (2019).
pubmed: 31000719 pmcid: 6472337 doi: 10.1038/s41467-019-09837-z
Jungnickel, K. E. J., Parker, J. L. & Newstead, S. Structural basis for amino acid transport by the CAT family of SLC7 transporters. Nat. Commun. 9, 550 (2018).
pubmed: 29416041 pmcid: 5803215 doi: 10.1038/s41467-018-03066-6
Lecina, D., Gilabert, J. F. & Guallar, V. Adaptive simulations, towards interactive protein-ligand modeling. Sci. Rep. 7, 8466 (2017).
pubmed: 28814780 pmcid: 5559483 doi: 10.1038/s41598-017-08445-5
Ilgu, H. et al. Insights into the molecular basis for substrate binding and specificity of the wild-type L-arginine/agmatine antiporter AdiC. Proc. Natl. Acad. Sci. USA 113, 10358–10363 (2016).
pubmed: 27582465 pmcid: 5027449 doi: 10.1073/pnas.1605442113
Meier, C., Ristic, Z., Klauser, S. & Verrey, F. Activation of system L heterodimeric amino acid exchangers by intracellular substrates. EMBO J. 21, 580–589 (2002).
pubmed: 11847106 pmcid: 125871 doi: 10.1093/emboj/21.4.580
Zhang, Y. W. et al. Structural elements required for coupling ion and substrate transport in the neurotransmitter transporter homolog LeuT. Proc. Natl. Acad. Sci. USA 115, E8854–E8862 (2018).
pubmed: 30181291 pmcid: 6156673 doi: 10.1073/pnas.1716870115
Lee Y., et al. Structural basis of anticancer drug recognition and amino acid transport by LAT1. bioRxiv 20231203567112, (2023).
Kimanius, D., Dong, L., Sharov, G., Nakane, T. & Scheres, S. H. W. New tools for automated cryo-EM single-particle analysis in RELION-4.0. Biochem. J. 478, 4169–4185 (2021).
pubmed: 34783343 doi: 10.1042/BCJ20210708
Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331–332 (2017).
pubmed: 28250466 pmcid: 5494038 doi: 10.1038/nmeth.4193
Rohou, A. & Grigorieff, N. CTFFIND4: fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 192, 216–221 (2015).
pubmed: 26278980 pmcid: 6760662 doi: 10.1016/j.jsb.2015.08.008
Gonzalez-Rodriguez, N., Arean-Ulloa, E. & Fernandez-Leiro, R. A web-based dashboard for RELION metadata visualization. Acta Crystallogr. D. Struct. Biol. 80, 93–100 (2024).
pubmed: 38265874 pmcid: 10836394 doi: 10.1107/S2059798323010902
Bepler, T. et al. Positive-unlabeled convolutional neural networks for particle picking in cryo-electron micrographs. Nat. Methods 16, 1153–1160 (2019).
pubmed: 31591578 pmcid: 6858545 doi: 10.1038/s41592-019-0575-8
Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296 (2017).
pubmed: 28165473 doi: 10.1038/nmeth.4169
Pettersen, E. F. et al. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).
pubmed: 15264254 doi: 10.1002/jcc.20084
Ramlaul, K., Palmer, C. M. & Aylett, C. H. S. A local agreement filtering algorithm for transmission EM reconstructions. J. Struct. Biol. 205, 30–40 (2019).
pubmed: 30502495 pmcid: 6351148 doi: 10.1016/j.jsb.2018.11.011
Terwilliger, T. C., Sobolev, O. V., Afonine, P. V. & Adams, P. D. Automated map sharpening by maximization of detail and connectivity. Acta Crystallogr. D. Struct. Biol. 74, 545–559 (2018).
pubmed: 29872005 pmcid: 6096490 doi: 10.1107/S2059798318004655
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D. Biol. Crystallogr. 66, 486–501 (2010).
pubmed: 20383002 pmcid: 2852313 doi: 10.1107/S0907444910007493
Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D. Biol. Crystallogr. 66, 213–221 (2010).
pubmed: 20124702 pmcid: 2815670 doi: 10.1107/S0907444909052925
Oliva, C. et al. Fibroblast phenylalanine concentration as a surrogate biomarker of cellular number. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 1226, 123787 (2023).
doi: 10.1016/j.jchromb.2023.123787
Hothorn, T., Bretz, F. & Westfall, P. Simultaneous inference in general parametric models. Biom. J. 50, 346–363 (2008).
pubmed: 18481363 doi: 10.1002/bimj.200810425
Team RC. R: A Language and Environment for Statistical Computing. R Core Team (). R Foundation for Statistical Computing, Vienna. https://www.R-project.org . (2021).
Sastry, G. M., Adzhigirey, M., Day, T., Annabhimoju, R. & Sherman, W. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J. Comput. Aided Mol. Des. 27, 221–234 (2013).
pubmed: 23579614 doi: 10.1007/s10822-013-9644-8
Gilabert, J. F., Lecina. D., Estrada, J. & Guallar, V. Monte Carlo techniques for drug design: the success case of PELE (eds Gervasio, F. L. & Spiwok, V.) 87–103, (Wiley, 2018).
Acebes, S. et al. Rational enzyme engineering through biophysical and biochemical modeling. ACS Catal. 6, 1624–1629 (2016).
Friesner, R. A. et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J. Med. Chem. 47, 1739–1749 (2004).
pubmed: 15027865 doi: 10.1021/jm0306430
Lomize, A. L., Pogozheva, I. D., Lomize, M. A. & Mosberg, H. I. Positioning of proteins in membranes: a computational approach. Protein Sci. 15, 1318–1333 (2006).
pubmed: 16731967 pmcid: 2242528 doi: 10.1110/ps.062126106
Lee, J. et al. CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 Additive Force Field. J. Chem. Theory Comput. 12, 405–413 (2016).
pubmed: 26631602 doi: 10.1021/acs.jctc.5b00935
Wu, E. L. et al. CHARMM-GUI membrane builder toward realistic biological membrane simulations. J. Comput Chem. 35, 1997–2004 (2014).
pubmed: 25130509 pmcid: 4165794 doi: 10.1002/jcc.23702
Jo, S., Lim, J. B., Klauda, J. B. & Im, W. CHARMM-GUI membrane Builder for mixed bilayers and its application to yeast membranes. Biophys. J. 97, 50–58 (2009).
pubmed: 19580743 pmcid: 2711372 doi: 10.1016/j.bpj.2009.04.013
Jo, S., Kim, T. & Im, W. Automated builder and database of protein/membrane complexes for molecular dynamics simulations. PLoS One 2, e880 (2007).
pubmed: 17849009 pmcid: 1963319 doi: 10.1371/journal.pone.0000880

Auteurs

Josep Rullo-Tubau (J)

Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Baldiri Reixac 10, E-08028, Barcelona, Spain.

Maria Martinez-Molledo (M)

Structural Biology Programme, Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro, 3, E-28029, Madrid, Spain.

Paola Bartoccioni (P)

Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Baldiri Reixac 10, E-08028, Barcelona, Spain.
The Spanish Center of Rare Diseases (CIBERER U-731), Baldiri Reixac 10, E-08028, Barcelona, Spain.

Ignasi Puch-Giner (I)

Electronic and atomic protein modelling group, Barcelona Supercomputing Center, Plaça d'Eusebi Güell, 1-3, E-08034, Barcelona, Spain.

Ángela Arias (Á)

Clinical Biochemistry Department, Sant Joan de Déu Research Institute, Pg. de Sant Joan de Déu, 2, E-08950, Esplugues de Llobregat, Spain.

Suwipa Saen-Oon (S)

Nostrum Biodiscovery, Av. de Josep Tarradellas, 8-10, E-08029, Barcelona, Spain.

Camille Stephan-Otto Attolini (C)

Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Baldiri Reixac 10, E-08028, Barcelona, Spain.

Rafael Artuch (R)

The Spanish Center of Rare Diseases (CIBERER U-731), Baldiri Reixac 10, E-08028, Barcelona, Spain.
Clinical Biochemistry Department, Sant Joan de Déu Research Institute, Pg. de Sant Joan de Déu, 2, E-08950, Esplugues de Llobregat, Spain.

Lucía Díaz (L)

Nostrum Biodiscovery, Av. de Josep Tarradellas, 8-10, E-08029, Barcelona, Spain.

Víctor Guallar (V)

Electronic and atomic protein modelling group, Barcelona Supercomputing Center, Plaça d'Eusebi Güell, 1-3, E-08034, Barcelona, Spain.
Nostrum Biodiscovery, Av. de Josep Tarradellas, 8-10, E-08029, Barcelona, Spain.

Ekaitz Errasti-Murugarren (E)

The Spanish Center of Rare Diseases (CIBERER U-731), Baldiri Reixac 10, E-08028, Barcelona, Spain. ekaitz_errasti@ub.edu.
Physiological Sciences Department, Genetics Area, School of Medicine and Health Sciences, University of Barcelona, Bellvitge Campus. Feixa Llarga s/n, E-08907, L'Hospitalet de Llobregat, Spain. ekaitz_errasti@ub.edu.
Human Molecular Genetics Laboratory, Gene, Disease and Therapy Program, IDIBELL, Hospital Duran i Reynals, Avd. Gran Via de L'Hospitalet 199, E-08908, L'Hospitalet de Llobregat, Spain. ekaitz_errasti@ub.edu.

Manuel Palacín (M)

Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Baldiri Reixac 10, E-08028, Barcelona, Spain. manuel.palacin@irbbarcelona.org.
The Spanish Center of Rare Diseases (CIBERER U-731), Baldiri Reixac 10, E-08028, Barcelona, Spain. manuel.palacin@irbbarcelona.org.
Department of Biochemistry and Molecular Biomedicine, University of Barcelona, Av. Diagonal, 643, E-08028, Barcelona, Spain. manuel.palacin@irbbarcelona.org.

Oscar Llorca (O)

Structural Biology Programme, Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro, 3, E-28029, Madrid, Spain. ollorca@cnio.es.

Classifications MeSH